ICU Medical, Inc. (NASDAQ:ICUI) Director George A. Lopez sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $205.83, for a total transaction of $1,029,150.00. Following the completion of the transaction, the director now directly owns 573,916 shares of the company’s stock, valued at approximately $118,129,130.28. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Shares of ICU Medical, Inc. (NASDAQ ICUI) traded down $1.15 during trading hours on Thursday, hitting $206.75. 118,500 shares of the company’s stock were exchanged, compared to its average volume of 127,745. The firm has a market cap of $4,185.14, a price-to-earnings ratio of 81.53, a P/E/G ratio of 18.53 and a beta of 0.33. ICU Medical, Inc. has a 52 week low of $127.00 and a 52 week high of $210.95. The company has a quick ratio of 3.01, a current ratio of 4.65 and a debt-to-equity ratio of 0.07.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, November 9th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.77 by $0.35. The company had revenue of $343.20 million during the quarter, compared to analyst estimates of $328.56 million. ICU Medical had a net margin of 2.79% and a return on equity of 4.81%. The company’s revenue for the quarter was up 253.5% on a year-over-year basis. During the same quarter last year, the business posted $1.35 EPS. sell-side analysts expect that ICU Medical, Inc. will post 0.71 earnings per share for the current year.

WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/16/icu-medical-inc-icui-director-sells-1029150-00-in-stock.html.

A number of research firms recently commented on ICUI. KeyCorp began coverage on shares of ICU Medical in a research note on Tuesday, October 17th. They issued a “sector weight” rating for the company. Zacks Investment Research raised shares of ICU Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. BidaskClub lowered shares of ICU Medical from a “hold” rating to a “sell” rating in a research note on Thursday, August 24th. Finally, Gabelli reissued a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $193.00.

Several large investors have recently modified their holdings of the business. California Public Employees Retirement System boosted its stake in shares of ICU Medical by 5.8% during the 3rd quarter. California Public Employees Retirement System now owns 28,342 shares of the medical instruments supplier’s stock valued at $5,267,000 after buying an additional 1,542 shares during the period. Cubist Systematic Strategies LLC bought a new position in shares of ICU Medical during the 3rd quarter valued at $572,000. Point72 Asset Management L.P. bought a new position in shares of ICU Medical during the 3rd quarter valued at $22,246,000. Janus Henderson Group PLC raised its holdings in shares of ICU Medical by 17.6% during the 3rd quarter. Janus Henderson Group PLC now owns 1,684,094 shares of the medical instruments supplier’s stock valued at $312,989,000 after purchasing an additional 251,793 shares in the last quarter. Finally, Segall Bryant & Hamill LLC bought a new position in shares of ICU Medical during the 3rd quarter valued at $12,589,000. 77.14% of the stock is owned by institutional investors.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.